Prophylactic Aortic Stent Prevents Massive Hemorrhage and Hematemesis After Definitive Esophageal Chemoradiation in a Patient With Pretreatment Aortic Involvement

Pract Radiat Oncol. 2019 Sep-Oct;9(5):e447-e451. doi: 10.1016/j.prro.2019.05.008. Epub 2019 May 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Aorta, Thoracic / diagnostic imaging
  • Aorta, Thoracic / pathology
  • Aorta, Thoracic / surgery*
  • Carboplatin / administration & dosage
  • Chemoradiotherapy / adverse effects*
  • Endovascular Procedures / instrumentation
  • Endovascular Procedures / methods*
  • Esophageal Neoplasms / diagnostic imaging
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Hematemesis / etiology
  • Hematemesis / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / diagnostic imaging
  • Paclitaxel / administration & dosage
  • Positron Emission Tomography Computed Tomography
  • Radiotherapy, Intensity-Modulated / adverse effects
  • Stents
  • Treatment Outcome

Substances

  • Carboplatin
  • Paclitaxel